601 related articles for article (PubMed ID: 25689414)
21. [Epigenetic mechanism of cardiac differentiation of stem cells].
Zhu H; Liu Y; Zhang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1217-21. PubMed ID: 22246356
[TBL] [Abstract][Full Text] [Related]
22. The epigenetics of breast cancer.
Jovanovic J; Rønneberg JA; Tost J; Kristensen V
Mol Oncol; 2010 Jun; 4(3):242-54. PubMed ID: 20627830
[TBL] [Abstract][Full Text] [Related]
23. Compendium of aberrant DNA methylation and histone modifications in cancer.
Hattori N; Ushijima T
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):3-9. PubMed ID: 25194808
[TBL] [Abstract][Full Text] [Related]
24. Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.
Oh S; Ko JY; Oh C; Yoo KH
Adv Exp Med Biol; 2017; 1026():287-313. PubMed ID: 29282690
[TBL] [Abstract][Full Text] [Related]
25. Aberrant epigenetic landscape in cancer: how cellular identity goes awry.
Berdasco M; Esteller M
Dev Cell; 2010 Nov; 19(5):698-711. PubMed ID: 21074720
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic Regulation in Breast Cancer.
Nam HJ; Baek SH
Adv Exp Med Biol; 2021; 1187():103-119. PubMed ID: 33983575
[TBL] [Abstract][Full Text] [Related]
27. Aberrant methylation of imprinted genes is associated with negative hormone receptor status in invasive breast cancer.
Barrow TM; Barault L; Ellsworth RE; Harris HR; Binder AM; Valente AL; Shriver CD; Michels KB
Int J Cancer; 2015 Aug; 137(3):537-47. PubMed ID: 25560175
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic utility of epigenetics in breast cancer - A review.
Bhat SA; Majid S; Wani HA; Rashid S
Cancer Treat Res Commun; 2019; 19():100125. PubMed ID: 30802811
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic and Therapeutic Implications of Histone Epigenetic Modulators in Breast Cancer.
Walsh L; Gallagher WM; O'Connor DP; Ní Chonghaile T
Expert Rev Mol Diagn; 2016; 16(5):541-51. PubMed ID: 26895288
[TBL] [Abstract][Full Text] [Related]
30. Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes.
Messier TL; Gordon JA; Boyd JR; Tye CE; Browne G; Stein JL; Lian JB; Stein GS
Oncotarget; 2016 Feb; 7(5):5094-109. PubMed ID: 26783963
[TBL] [Abstract][Full Text] [Related]
31. DNA methylation and miRNAs regulation in hereditary breast cancer: epigenetic changes, players in transcriptional and post- transcriptional regulation in hereditary breast cancer.
Pinto R; De Summa S; Pilato B; Tommasi S
Curr Mol Med; 2014 Jan; 14(1):45-57. PubMed ID: 24295492
[TBL] [Abstract][Full Text] [Related]
32. Epigenetics in breast cancer: what's new?
Huang Y; Nayak S; Jankowitz R; Davidson NE; Oesterreich S
Breast Cancer Res; 2011; 13(6):225. PubMed ID: 22078060
[TBL] [Abstract][Full Text] [Related]
33. Epigenetics in prostate cancer: biologic and clinical relevance.
Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer: mechanisms involved in action of phytoestrogens and epigenetic changes.
Dagdemir A; Durif J; Ngollo M; Bignon YJ; Bernard-Gallon D
In Vivo; 2013; 27(1):1-9. PubMed ID: 23239847
[TBL] [Abstract][Full Text] [Related]
36. Epigenetics in breast and prostate cancer.
Wu Y; Sarkissyan M; Vadgama JV
Methods Mol Biol; 2015; 1238():425-66. PubMed ID: 25421674
[TBL] [Abstract][Full Text] [Related]
37. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
[TBL] [Abstract][Full Text] [Related]
38. [Lung cancer and epigenetic modifications].
Darılmaz Yüce G; Ortaç Ersoy E
Tuberk Toraks; 2016 Jun; 64(2):163-70. PubMed ID: 27481083
[TBL] [Abstract][Full Text] [Related]
39. The value of epigenetic biomarkers in breast cancer.
Parrella P
Biomark Med; 2018 Sep; 12(9):937-940. PubMed ID: 30041537
[No Abstract] [Full Text] [Related]
40. SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells.
Cuomo A; Moretti S; Minucci S; Bonaldi T
Amino Acids; 2011 Jul; 41(2):387-99. PubMed ID: 20617350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
